Metsera, Inc Common Stock

Yahoo Finance • 2 days ago

$HAREHOLDER ALERT: The M&A Class Action Launches Legal Inquiry for the Merger – MTSR, GES, BLBX, and SCS

NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the... Full story

Yahoo Finance • 3 days ago

Should You Buy Pfizer (PFE) Before a Breakout Begins?

We recently published Top 10 Trending Stocks as Famous Billionaire Predicts Massive AI Stock Rally Before Bubble Burst. Pfizer Inc (NYSE:PFE) is one of the trending stocks. Analysts are getting excited about major healthcare stocks like P... Full story

Yahoo Finance • 4 days ago

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates PINC, MTSR, HOUS, ODP on Behalf of Shareholders

NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 4 days ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Premier, Inc. (Nasdaq – PINC), Metsera, Inc. (Nasdaq – MTSR), Anywhere Real Estate Inc. (NYSE – HOUS), The ODP Corporation (Nasdaq – ODP)

BALA CYNWYD, Pa., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ack... Full story

Yahoo Finance • 5 days ago

SA Asks: What's the most attractive Big Pharma stock right now?

[Pfizer HQ in New York City] georgeclerk What's the most attractive Big Pharma stock right now? We asked Seeking Alpha analysts The Value Portfolio [https://seekingalpha.com/author/the-value-portfolio] and ALLKA Research [https://seeking... Full story

Yahoo Finance • 10 days ago

Pfizer (PFE): A Healthcare Giant Offering Steady Dividend Income

Pfizer Inc. (NYSE:PFE) is included among the 10 Highest Dividend-Paying Stocks to Buy in the S&P 500.Pfizer (PFE): A Healthcare Giant Offering Steady Dividend Income Pfizer Inc. (NYSE:PFE) is a US pharmaceutical and biotech giant that pro... Full story

Yahoo Finance • 11 days ago

BTIG Reiterates a Buy Rating on Viking Therapeutics (VKTX) With a $125 PT

Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the best strong buy stocks to invest in according to Wall Street. On September 22, BTIG analyst Justin Zelin reiterated a Buy rating on Viking Therapeutics, Inc. (NASDAQ:VKTX) and set a $12... Full story

Yahoo Finance • 11 days ago

Bank of America Securities Maintains a Neutral Stance on Pfizer Inc. (PFE)

Pfizer Inc. (NYSE:PFE) is one of the best large cap value stocks to buy now. On September 23, Bank of America Securities analyst Tim Anderson maintained a neutral stance on Pfizer Inc. (NYSE:PFE), giving the stock a Hold rating with a $28... Full story

Yahoo Finance • 11 days ago

Metsera Posts Promising Weight-Loss Drug Results. It Could Be a Win for Pfizer.

Pfizer said last week it would pay $47.50 per share for Metsera, and an extra $22.50 per share if its drugs hit certain milestones. Continue Reading View Comments... Full story

Yahoo Finance • 11 days ago

Metsera ultra-long acting GLP-1 MET-097i excels in mid-stage trial

[Two injectors / dosing pens for subcutaneous injection of antidiabetic medication or anti-obesity medication hovering over a blue background. A yellow measuring tape around the injectors.] aprott/iStock via Getty Images * Metsera's (NA... Full story

Yahoo Finance • 12 days ago

Metsera Reports Positive Phase 2b Results for First- and Best-in-Class Ultra-long Acting GLP-1 RA Candidate MET-097i, Enabling Rapid Transition into Phase 3

Placebo-subtracted mean weight loss up to 14.1%after 28 weeks with no plateau Potential for best-in-class tolerability with minimal diarrhea signal, 13% nausea, and 11% vomiting High study and treatment retention in both VESPER-1 and VES... Full story

Yahoo Finance • 12 days ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PINC, MTSR, HOUS, ODP on Behalf of Shareholders

NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to sharehold... Full story

Yahoo Finance • 12 days ago

BMO Capital Maintains a Buy on Pfizer Inc (PFE), Keeps the PT

​Pfizer Inc. (NYSE:PFE) is one of the Most Undervalued Growth Stocks to Buy According to Hedge Funds. On September 22, Evan Seigerman from BMO Capital maintained a Buy rating on Pfizer Inc. (NYSE:PFE) with a price target of $30. ​The anal... Full story

Yahoo Finance • 13 days ago

Down 55%, Should You Buy the Dip on Pfizer?

Key Points Pfizer stands as one of the largest drug makers in the world. It faces normal industry challenges, but it also has a lofty payout ratio. Its latest acquisition shows what it is capable of doing to get onto a better path. 10 sto... Full story

Yahoo Finance • 13 days ago

Notable healthcare headlines for the week: Novo Nordisk, Hims & Hers and UnitedHealth in focus

The S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500#hasComeFromMpArticle=false#source=section%3Amain_content%7Cbutton%3Abody_link%7Cfirst_level_url%3Anews]) closed in the green on Friday, after the latest inflation data increased opt... Full story

Yahoo Finance • 14 days ago

Key deals this week: STAAR Surgical, Pfizer, DB Insurance, Strive, Rocket Lab and more

Here's a list of key deals reported across sectors this week: * STAAR Surgical (NASDAQ:STAA [https://seekingalpha.com/symbol/STAA]) said in a presentation that its $28.00 per share all-cash merger [https://seekingalpha.com/news/4499588-... Full story

Yahoo Finance • 14 days ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PINC, MTSR, ETNB on Behalf of Shareholders

NEW YORK, Sept. 27, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to sharehold... Full story

Yahoo Finance • 14 days ago

$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger – MTSR, HOUS, PINC, and FNBT

NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in t... Full story

Yahoo Finance • 16 days ago

Metsera downgraded to Market Perform from Outperform at Leerink

Leerink downgraded Metsera (MTSR) to Market Perform from Outperform with a price target of $57, down from $77, after Pfizer (PFE) announced an agreement to acquire Metsera for $4.9B upfront and total potential deal value of about $7.3B con... Full story

Yahoo Finance • 17 days ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARIS, MTSR, GTLS, MURA on Behalf of Shareholders

NEW YORK, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to sharehold... Full story